Rhode Island SB 494: AN ACT RELATING TO INSURANCE (Requires drug companies disclose to office of the health insurance commissioner acquisition costs of drugs approved by FDA, if acquisition cost is at least $100 for 30 day supply and requires disclosure of rebates, price protection payments.)

Status: 06/24/2021 Senate passed Sub A (as of 2021-06-24)

State: Rhode Island · Session: 2021 · Bill: SB 494

Subjects: Drugs, Health Insurance, Insurance, Prescription drugs

Sponsors: Coyne, Goodwin, McCaffrey, Miller, Ruggerio

View Rhode Island SB 494 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.